Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis

Drug-resistant tuberculosis and extrapulmonary tuberculosis are the world major public health issues. Although some primary studies have been reported on the burden of drug-resistant tuberculosis in extrapulmonary tuberculosis patients in Ethiopia, there is no systematic review and meta-analysis tha...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2021-10, Vol.16 (10), p.e0258295-e0258295
Main Authors: Diriba, Getu, Tola, Habteyes Hailu, Alemu, Ayinalem, Yenew, Bazezew, Gamtesa, Dinka Fikadu, Kebede, Abebaw
Format: Article
Language:English
Subjects:
Care and treatment
Drug resistance
Drug resistance in microorganisms
Evaluation
Health risks
Isoniazid
Laboratories
Medicine and Health Sciences
Meta-analysis
Multidrug resistance
Patients
People and Places
Physical Sciences
Public health
Research and Analysis Methods
Resistance factors
Rifampin
Risk analysis
Risk factors
Systematic review
Tuberculosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Drug-resistant tuberculosis and extrapulmonary tuberculosis are the world major public health issues. Although some primary studies have been reported on the burden of drug-resistant tuberculosis in extrapulmonary tuberculosis patients in Ethiopia, there is no systematic review and meta-analysis that attempt to summarize the available literature. Thus, we aimed to estimates the prevalence of drug-resistance in extrapulmonary tuberculosis patients and summarize the risk factors associated with the occurrence of extrapulmonary tuberculosis in Ethiopia. We conducted a systematic review of the published primary studies on extrapulmonary drug-resistant tuberculosis in Ethiopia. Eight observational studies were included in this review from different regions of Ethiopia. The overall pooled prevalence of rifampicin resistance was 6% (95% CI 0.03-0.10), while isoniazid resistance was 7% (95% CI 0.03-0.12). The pooled prevalence of multidrug-resistant tuberculosis was 4% (95% CI 0.01-0.07). Previous tuberculosis treatment history and male gender are frequently reported risk factors for developing drug-resistant tuberculosis in extrapulmonary tuberculosis patients. The current review has identified a high proportion of resistance to rifampicin, isoniazid, and multidrug-resistant tuberculosis in patients with extrapulmonary tuberculosis in Ethiopia. Clinicians should request drug susceptibility testing for all patients with presumptive extrapulmonary tuberculosis to detect drug-resistance.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0258295